ClinicalTrials.govpublic full text
Phase 1 and 2 Study of PX-866 and Cetuximab
incurable metastatic colorectal carcinoma, incurable progressive, recurrent or metastatic squamous cell carcinoma of the head and neck, crc, scchn, px-866, cetuximab, erbitux, colon, head and neck, colorectal cancer, squamous cell carcinoma, pi-3k
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1009226
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.